TY - JOUR
T1 - Effect of an Arsenic Mitigation Program on Arsenic Exposure in American Indian Communities
T2 - A Cluster Randomized Controlled Trial of the Community-Led Strong Heart Water Study Program
AU - George, Christine Marie
AU - Zacher, Tracy
AU - Endres, Kelly
AU - Richards, Francine
AU - Robe, Lisa Bear
AU - Harvey, David
AU - Best, Lyle G.
AU - Cloud, Reno Red
AU - Bear, Annabelle Black
AU - Skinner, Leslie
AU - Cuny, Christa
AU - Rule, Ana
AU - Schwab, Kellogg J.
AU - Gittelsohn, Joel
AU - Glabonjat, Ronald Alexander
AU - Schilling, Kathrin
AU - O’leary, Marcia
AU - Thomas, Elizabeth D.
AU - Umans, Jason
AU - Zhu, Jianhui
AU - Moulton, Lawrence Hale
AU - Navas Acien, Ana
N1 - Publisher Copyright:
© 2024, Public Health Services, US Dept of Health and Human Services. All rights reserved.
PY - 2024
Y1 - 2024
N2 - BACKGROUND: Chronic arsenic exposure has been associated with an increased risk of cardiovascular disease; diabetes; cancers of the lung, pancreas and prostate; and all-cause mortality in American Indian communities in the Strong Heart Study. OBJECTIVE: The Strong Heart Water Study (SHWS) designed and evaluated a multilevel, community-led arsenic mitigation program to reduce arsenic exposure among private well users in partnership with Northern Great Plains American Indian Nations. METHODS: A cluster randomized controlled trial (cRCT) was conducted to evaluate the effectiveness of the SHWS arsenic mitigation program over a 2-y period on a) urinary arsenic, and b) reported use of arsenic-safe water for drinking and cooking. The cRCT compared the installation of a pointof-use arsenic filter and a mobile Health (mHealth) program (3 phone calls; SHWS mHealth and Filter arm) to a more intensive program, which included this same program plus three home visits (3 phone calls and 3 home visits; SHWS Intensive arm). RESULTS: A 47% reduction in urinary arsenic [geometric mean (GM) = 13:2 to 7:0 μg/g creatinine] was observed from baseline to the final follow-up when both study arms were combined. By treatment arm, the reduction in urinary arsenic from baseline to the final follow-up visit was 55% in the mHealth and Filter arm (GM = 14:6 to 6:55 μg/g creatinine) and 30% in the Intensive arm (GM = 11:2 to 7:82 μg/g creatinine). There was no significant difference in urinary arsenic levels by treatment arm at the final follow-up visit comparing the Intensive vs. mHealth and Filter arms: GM ratio of 1.21 (95% confidence interval: 0.77, 1.90). In both arms combined, exclusive use of arsenic-safe water from baseline to the final follow-up visit significantly increased for water used for cooking (17% to 53%) and drinking (12% to 46%). DISCUSSION: Delivery of the interventions for the community-led SHWS arsenic mitigation program, including the installation of a point-of-use arsenic filter and a mHealth program on the use of arsenic-safe water (calls only, no home visits), resulted in a significant reduction in urinary arsenic and increases in reported use of arsenic-safe water for drinking and cooking during the 2-y study period. These results demonstrate that the installation of an arsenic filter and phone calls from a mHealth program presents a promising approach to reduce water arsenic exposure among private well users.
AB - BACKGROUND: Chronic arsenic exposure has been associated with an increased risk of cardiovascular disease; diabetes; cancers of the lung, pancreas and prostate; and all-cause mortality in American Indian communities in the Strong Heart Study. OBJECTIVE: The Strong Heart Water Study (SHWS) designed and evaluated a multilevel, community-led arsenic mitigation program to reduce arsenic exposure among private well users in partnership with Northern Great Plains American Indian Nations. METHODS: A cluster randomized controlled trial (cRCT) was conducted to evaluate the effectiveness of the SHWS arsenic mitigation program over a 2-y period on a) urinary arsenic, and b) reported use of arsenic-safe water for drinking and cooking. The cRCT compared the installation of a pointof-use arsenic filter and a mobile Health (mHealth) program (3 phone calls; SHWS mHealth and Filter arm) to a more intensive program, which included this same program plus three home visits (3 phone calls and 3 home visits; SHWS Intensive arm). RESULTS: A 47% reduction in urinary arsenic [geometric mean (GM) = 13:2 to 7:0 μg/g creatinine] was observed from baseline to the final follow-up when both study arms were combined. By treatment arm, the reduction in urinary arsenic from baseline to the final follow-up visit was 55% in the mHealth and Filter arm (GM = 14:6 to 6:55 μg/g creatinine) and 30% in the Intensive arm (GM = 11:2 to 7:82 μg/g creatinine). There was no significant difference in urinary arsenic levels by treatment arm at the final follow-up visit comparing the Intensive vs. mHealth and Filter arms: GM ratio of 1.21 (95% confidence interval: 0.77, 1.90). In both arms combined, exclusive use of arsenic-safe water from baseline to the final follow-up visit significantly increased for water used for cooking (17% to 53%) and drinking (12% to 46%). DISCUSSION: Delivery of the interventions for the community-led SHWS arsenic mitigation program, including the installation of a point-of-use arsenic filter and a mHealth program on the use of arsenic-safe water (calls only, no home visits), resulted in a significant reduction in urinary arsenic and increases in reported use of arsenic-safe water for drinking and cooking during the 2-y study period. These results demonstrate that the installation of an arsenic filter and phone calls from a mHealth program presents a promising approach to reduce water arsenic exposure among private well users.
UR - http://www.scopus.com/inward/record.url?scp=85189261947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85189261947&partnerID=8YFLogxK
U2 - 10.1289/EHP12548
DO - 10.1289/EHP12548
M3 - Article
C2 - 38534131
AN - SCOPUS:85189261947
SN - 0091-6765
VL - 132
JO - Environmental health perspectives
JF - Environmental health perspectives
IS - 3
M1 - 037007
ER -